Sec Form 4 Filing - LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP @ Teligent, Inc. - 2020-08-19

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP 2. Issuer Name and Ticker or Trading Symbol Teligent, Inc. [ TLGT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 152 WEST 57TH STREET, 59TH FLOOR 3. Date of Earliest Transaction (MM/DD/YY) 08/19/2020 (Street) NEW YORK, NY10019 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/19/2020 S 74,020 D $ 2.2565 761,680 D ( 1 ) Common Stock 08/19/2020 S 13,251 D $ 2.2459 136,237 D ( 2 ) Common Stock 08/21/2020 S 102,962 D $ 1.6615 658,718 D ( 1 ) Common Stock 08/21/2020 S 18,432 D $ 1.6569 117,805 D ( 2 ) Common Stock 08/25/2020 S 84,816 D $ 1.1336 573,902 D ( 1 ) Common Stock 08/25/2020 S 15,184 D $ 1.1266 102,621 D ( 2 ) Common Stock 08/26/2020 S 475,512 D $ 1.2435 98,390 D ( 1 ) Common Stock 08/26/2020 S 85,106 D $ 1.2478 17,515 D ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP 152 WEST 57TH STREET 59TH FLOOR NEW YORK, NY10019 X X LIFE SCIENCES OPPORTUNITIES FUND II LP 152 WEST 57TH STREET 59TH FLOOR NEW YORK, NY10019 X SIGNET HEALTHCARE PARTNERS, LLC 152 WEST 57TH STREET 59TH FLOOR NEW YORK, NY10019 X GALE JAMES C 152 WEST 57TH STREET 59TH FLOOR NEW YORK, NY10019 X X SANDERS DON A 600 TRAVIS, SUITE 5900 HOUSTON, TX77002 X MORRIS BEN T 600 TRAVIS, SUITE 5900 HOUSTON, TX77002 X WEIR DONALD V 600 TRAVIS, SUITE 5900 HOUSTON, TX77002 X Signatures /s/ James C. Gale, Manager 09/16/2020 Signature of Reporting Person Date /s/ James C. Gale, Manager 09/16/2020 Signature of Reporting Person Date /s/ James C. Gale 09/16/2020 Signature of Reporting Person Date /s/ James C. Gale, Manager 09/16/2020 Signature of Reporting Person Date /s/ Don Sanders 09/16/2020 Signature of Reporting Person Date /s/ Ben Morris 09/16/2020 Signature of Reporting Person Date /s/ Donald Weir 09/16/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. ( 2 )These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.

Remarks: This is a joint filing by Life Sciences Opportunities Fund (Institutional) II, L.P., Life Sciences Opportunities Fund II, L.P., the General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir. The address of each filer is the same as the designated filer except SMW, Mr. Sanders, Mr. Morris, and Mr. Weir, which is 600 Travis, Suite 5900, Houston, Texas 77002. Mr. Gale served on the Teligent, Inc.. board of directors until July 15, 2020.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.